Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,136 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Exercise-induced bronchoconstriction in school-aged children who had chronic lung disease in infancy.
Joshi S, Powell T, Watkins WJ, Drayton M, Williams EM, Kotecha S. Joshi S, et al. Among authors: powell t. J Pediatr. 2013 Apr;162(4):813-818.e1. doi: 10.1016/j.jpeds.2012.09.040. Epub 2012 Oct 27. J Pediatr. 2013. PMID: 23110946
Effect of resistive load on the inspiratory work and power of breathing during exertion.
Powell T, Williams EM. Powell T, et al. PLoS One. 2012;7(11):e49681. doi: 10.1371/journal.pone.0049681. Epub 2012 Nov 27. PLoS One. 2012. PMID: 23209590 Free PMC article.
Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease.
Jorquera PA, Choi Y, Oakley KE, Powell TJ, Boyd JG, Palath N, Haynes LM, Anderson LJ, Tripp RA. Jorquera PA, et al. Among authors: powell tj. PLoS One. 2013 Sep 10;8(9):e74905. doi: 10.1371/journal.pone.0074905. eCollection 2013. PLoS One. 2013. PMID: 24040360 Free PMC article.
Remarkably, RSV challenge of G protein nanoparticle vaccinated mice resulted in increased RSV M2-specific IL-4 and IFN-γ secreting T cells, and increased M2-specific H-2Kd-tetramer positive CD8(+) T cells in the lungs compared to controls. ...These results demonstra …
Remarkably, RSV challenge of G protein nanoparticle vaccinated mice resulted in increased RSV M2-specific IL-4 and IFN-γ secreting T
Layer-By-Layer Nanoparticle Vaccines Carrying the G Protein CX3C Motif Protect against RSV Infection and Disease.
Jorquera PA, Oakley KE, Powell TJ, Palath N, Boyd JG, Tripp RA. Jorquera PA, et al. Among authors: powell tj. Vaccines (Basel). 2015 Oct 12;3(4):829-49. doi: 10.3390/vaccines3040829. Vaccines (Basel). 2015. PMID: 26473935 Free PMC article.
Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needs.
Song L, Nakaar V, Kavita U, Price A, Huleatt J, Tang J, Jacobs A, Liu G, Huang Y, Desai P, Maksymiuk G, Takahashi V, Umlauf S, Reiserova L, Bell R, Li H, Zhang Y, McDonald WF, Powell TJ, Tussey L. Song L, et al. Among authors: powell tj. PLoS One. 2008 May 21;3(5):e2257. doi: 10.1371/journal.pone.0002257. PLoS One. 2008. PMID: 18493310 Free PMC article.
Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivo.
Powell TJ, Palath N, DeRome ME, Tang J, Jacobs A, Boyd JG. Powell TJ, et al. Vaccine. 2011 Jan 10;29(3):558-69. doi: 10.1016/j.vaccine.2010.10.001. Epub 2010 Oct 15. Vaccine. 2011. PMID: 20951665
LbL nanoparticle delivery of designed peptides to DC resulted in potent cross-presentation to CD8+ T-cells and more efficient presentation to CD4+ T-cells compared to presentation of soluble peptide. A single immunization of mice with LbL nanoparticles containing de …
LbL nanoparticle delivery of designed peptides to DC resulted in potent cross-presentation to CD8+ T-cells and more efficient present …
Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.
Powell TJ, Tang J, Derome ME, Mitchell RA, Jacobs A, Deng Y, Palath N, Cardenas E, Boyd JG, Nardin E. Powell TJ, et al. Vaccine. 2013 Apr 8;31(15):1898-904. doi: 10.1016/j.vaccine.2013.02.027. Epub 2013 Feb 26. Vaccine. 2013. PMID: 23481177 Free PMC article.
An innovative method for producing particle vaccines, layer-by-layer (LbL) fabrication of polypeptide films on solid CaCO3 cores, was used to produce synthetic malaria vaccines containing a tri-epitope CS peptide T1BT comprising the antibody epitope of the CS repeat region (B) an …
An innovative method for producing particle vaccines, layer-by-layer (LbL) fabrication of polypeptide films on solid CaCO3 cores, was used t …
Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
Huleatt JW, Nakaar V, Desai P, Huang Y, Hewitt D, Jacobs A, Tang J, McDonald W, Song L, Evans RK, Umlauf S, Tussey L, Powell TJ. Huleatt JW, et al. Among authors: powell tj. Vaccine. 2008 Jan 10;26(2):201-14. doi: 10.1016/j.vaccine.2007.10.062. Epub 2007 Nov 20. Vaccine. 2008. PMID: 18063235
Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.
Huleatt JW, Jacobs AR, Tang J, Desai P, Kopp EB, Huang Y, Song L, Nakaar V, Powell TJ. Huleatt JW, et al. Among authors: powell tj. Vaccine. 2007 Jan 8;25(4):763-75. doi: 10.1016/j.vaccine.2006.08.013. Epub 2006 Aug 22. Vaccine. 2007. PMID: 16968658
These included rapid and consistent antigen-specific IgG(1) and IgG(2a) antibody responses that were detectable within 7 days of immunization, and the development of protective CD8 T cell responses. ...Animals immunized with this recombinant protein demonstrated significan …
These included rapid and consistent antigen-specific IgG(1) and IgG(2a) antibody responses that were detectable within 7 days of immunizatio …
A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
McDonald WF, Huleatt JW, Foellmer HG, Hewitt D, Tang J, Desai P, Price A, Jacobs A, Takahashi VN, Huang Y, Nakaar V, Alexopoulou L, Fikrig E, Powell TJ. McDonald WF, et al. Among authors: powell tj. J Infect Dis. 2007 Jun 1;195(11):1607-17. doi: 10.1086/517613. Epub 2007 Apr 17. J Infect Dis. 2007. PMID: 17471430
1,136 results
Jump to page
Feedback